EMULATE THERAPEUTICS Trademark

Trademark Overview


On Friday, April 29, 2022, a trademark application was filed for EMULATE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EMULATE THERAPEUTICS trademark a serial number of 97389517. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Wednesday, February 14, 2024. This trademark is owned by EMulate Therapeutics, Inc.. The EMULATE THERAPEUTICS trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

Medical apparatus for use in treating cancer, pain, inflammation, and solid cancer tumors such as mycosis fungoides, plasma cell tumors, fibrosarcomas, neurofibrosarcomas, schwannomas, malignant melanomas, hermangiopericytomas, hepatic adenocarcinomas, mast cell tumors, mammary adenocarcinomas, osteosarcomas, chondrosarcomas, apocrine glandadenocarcinomas, undifferentiated carcinomas, and transitional cell carcinomas tumors, and mental health conditions, namely, PTSD, depression, anxiety and addiction; Medical device for treating cancer

Product development in the field of medical device technology; Research and development in the field of medical device technology for use in treating cancer, pain, inflammation, tumors, and a wide range of ailments and disease; Research and development of technology in the field of disease treatment
emulate therapeutics

General Information


Serial Number97389517
Word MarkEMULATE THERAPEUTICS
Filing DateFriday, April 29, 2022
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateWednesday, February 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements


Goods and ServicesMedical apparatus for use in treating cancer, pain, inflammation, and solid cancer tumors such as mycosis fungoides, plasma cell tumors, fibrosarcomas, neurofibrosarcomas, schwannomas, malignant melanomas, hermangiopericytomas, hepatic adenocarcinomas, mast cell tumors, mammary adenocarcinomas, osteosarcomas, chondrosarcomas, apocrine glandadenocarcinomas, undifferentiated carcinomas, and transitional cell carcinomas tumors, and mental health conditions, namely, PTSD, depression, anxiety and addiction; Medical device for treating cancer
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesProduct development in the field of medical device technology; Research and development in the field of medical device technology for use in treating cancer, pain, inflammation, tumors, and a wide range of ailments and disease; Research and development of technology in the field of disease treatment

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code8 - Abandoned
Class Status DateWednesday, February 14, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateWednesday, February 14, 2024
Primary Code042
First Use Anywhere DateFriday, November 30, 2018
First Use In Commerce DateFriday, November 30, 2018

Trademark Owner History


Party NameEMulate Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameEMulate Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Thursday, February 15, 2024ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Wednesday, February 14, 2024OPPOSITION TERMINATED NO. 999999
Wednesday, February 14, 2024OPPOSITION SUSTAINED NO. 999999
Wednesday, February 14, 2024ABANDONMENT - AFTER INTER PARTES DECISION
Wednesday, November 15, 2023OPPOSITION INSTITUTED NO. 999999
Friday, August 11, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 14, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, June 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 7, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, June 7, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 6, 2023ASSIGNED TO LIE
Friday, February 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 17, 2023NON-FINAL ACTION E-MAILED
Friday, February 17, 2023NON-FINAL ACTION WRITTEN
Thursday, February 16, 2023ASSIGNED TO EXAMINER
Wednesday, May 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 3, 2022NEW APPLICATION ENTERED